CTQ Careteq Limited
Healthcare · Health Information Services
· website
$0.01
52wk 0.01 – 0.02
Overall
77.9
Value
87.2
Growth
100.0
Health
100.0
Quality
0.0
Momentum
84.5
Dividend
—
Price
About Careteq Limited
Careteq Limited engages in medication management and clinical governance for health, aged, and home care sectors in Australia. The company was incorporated in 2016 and is headquartered in Melbourne, Australia.
Price analytics
Returns
| 1 day | 0.0% |
| 1 week | -6.7% |
| 1 month | 7.7% |
| 3 months | 7.7% |
| 6 months | 100.0% |
| 1 year | 16.7% |
| 3 years | -46.2% |
Risk
| Volatility (1y ann.) | 109.4% |
| Beta vs ASX 200 | -0.83 |
| Sharpe (1y) | 0.63 |
| VaR 95% (1-day) | -9.1% |
| Max drawdown (1y) | -41.7% |
| Off 1-year high | -26.3% |
Technicals
| RSI(14) | 47 |
| vs 50DMA | 4.5% |
| vs 200DMA | 24.1% |
| Trend | Golden cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
87.2
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
62
Price / Sales
90
Growth
100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
84.5
6-month return vs ASX 200
100
Price vs 200-day average
100
Price vs 50-day average
72
Position in 52-week range
54
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$10.26M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
1.06
EV / EBITDA
-3.56
Price / Book
3.50
ROE
-16.8%
Operating margin
-24.9%
Net margin
-6.5%
Total cash
$3.19M
Total debt
$47,563
Current ratio
6.04
Debt / Equity
0.01
Free cash flow
$-802,190
Avg volume
1.36M
Latest annual results
(FY ending 30 Jun 2025)
- Revenue—
- Gross profit—
- Operating income—
- Net income—
- Diluted EPS-0.00
- Free cash flow—
- Net debt—